All BCG articles
-
NewsScientists ID ‘unconventional’ new pathway for TB vaccines
Marginal zone B (MZB) cells are a natural response to TB infection which has been long overlooked - and which might be a welcome new target.
-
NewsRecombinant protein offers potential as TB booster vaccine
No new vaccine has yet surpassed BCG, which is a highly effective live vaccine and is very effective in preventing tuberculosis in children. Creating a booster vaccine to strengthen immunity in adults is considered a promising and realistic option.
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsBCG mechanism extends protection to beat influenza A
A new study uncovered a previously unknown mechanism that extends the BCG vaccine’s shield to combat influenza A virus—the most prevalent flu strain.
-
NewsVaccine boosts innate immunity in people with dormant immune cells
Epigenetic cell states predict whether or not an individual profits from the “wake-up call” to the innate immune system that is provided by the BCG vaccine.
-
NewsResearchers develop a new TB vaccine testing model by leveraging old BCG vaccine
Each year, tuberculosis (TB) kills more people than any other infectious disease, falling out of the top spot only temporarily during the COVID-19 pandemic. Source: Saint Louis University Daniel Hoft, M.D., Ph.D., director of the Saint Louis University Center for Vaccine Development Despite TB’s wide reach and ...
-
NewsTB vaccine discovery paves path to end no. 1 killer of people living with HIV
Scientists have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
-
NewsConsortium awarded €9M to create better tuberculosis vaccine
Researchers from the University of Leicester are among those hoping to create an improved vaccine to fight tuberculosis as part of a €9 million Euro project.
-
NewsBCG vaccine found ineffective against COVID-19 in healthcare workers
An international trial investigating the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19 found that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for.
-
NewsBCG does not protect health workers against Covid
A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.
